Showing results (1991-2000 of 2,535) with videos related to

Sort By:
Pageof 254
American Journal of Surgery|May 31, 1988
Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitinS E Wilson, J A Boswick, R J Duma, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2014
The discovery of potent, orally bioavailable pyrimidine-5-carbonitrile-6-alkyl CXCR2 receptor antagonistsDavid W Porter, Michelle Bradley, Zarin Brown, et al.
Pediatric Neurology|February 2, 2023
The Spectrum of Quantitative EEG Utilization Across North America: A Cross-Sectional SurveyGiulia M Benedetti, Lindsey A Morgan, Arnold J Sansevere, et al.
Resuscitation|November 9, 2025
Severe intracranial hemorrhage or ischemia associated with unfavorable outcomes after pediatric in-hospital cardiac arrestNatalie L Ullman, Ron W Reeder, Alexis Topjian, et al.
Mbio|October 30, 2024
Genetic variation in individuals from a population of the minimalist bacteriophage Merri-merri-uth nyilam marra-natj driving evolution of the virusTze Y Thung, Alex Hall, Afif P Jati, et al.
Protein Engineering, Design & Selection : PEDS|June 10, 2004
Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targetingTove Olafsen, Giselle J Tan, Chia-Wei Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Molecular determinants of cetuximab efficacyDaniel Vallböhmer, Wu Zhang, Michael Gordon, et al.
Advances in Radiation Oncology|July 21, 2025
Clinical Outcomes After Proton Therapy Reirradiation for Recurrent Malignant Glioma: Analysis From the Prospective Proton Collaborative Group RegistryOmer Gal, Stephen Mihalcik, Lia M Halasz, et al.
Pharmacogenetics and Genomics|June 22, 2006
Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with CetuximabWu Zhang, Michael Gordon, Oliver A Press, et al.
NPJ Breast Cancer|October 9, 2021
A careful reassessment of anthracycline use in curable breast cancerSara Alsterlind Hurvitz, Nicholas P McAndrew, Aditya Bardia, et al.
Pageof 254